Skip to content

Monopar Therapeutics

MNPR Nasdaq SEC CIK 1645469

Follow Monopar Therapeutics Weekly email: filings, results, news

News

3 stories filed under Monopar Therapeutics, grouped into ongoing threads

Therapeutics director

Thread · 2 stories

Monopar Therapeutics director Kim Tsuchimoto sells $455,566 in shares

Markets 27 d ago 3 sources

Monopar Therapeutics director Raymond Anderson sells $351,835 in stock

Markets 27 d ago 2 sources

More coverage

Monopar Therapeutics acting CMO sells $111 of stock, exercises options

Markets 28 d ago 2 sources

Profile

Headquarters: WILMETTE, IL, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Latest filings

Q2 2026 report10-Q · 12 Aug 2026

Peers

Where this page comes from

Profile · SEC EDGAR

Financials · SEC EDGAR filing dates

News · 3 stories clustered from the RSS aggregator